[Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia]. 1978

G G Chichkanov, and A K Bogolepov

In experimental angina pectoris of dogs developed by Sze-keres et al, 1976, and modified by the authors it was shown that nonachlazine in doses of 3 and 5 mg/kg decreased or even completely prevented the ST segment elevation on the epicardial electrogram from the focus of myocardial ischemia. Oxyphedrine in doses of 0.05, 0.1, and 0,3 mg/kg had no such effect. In doses of 0.1 and 0.3 mg/kg the drug aggravated the epicardial electrogram.

UI MeSH Term Description Entries
D009628 Nonachlazine Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent. Azaclorzine,Nonachlazin,Nonakhlazin
D010099 Oxyfedrine A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent. Oxyphedrin,Ildamen,Myofedrin,Oxifedrine,Oxiphedrin
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G G Chichkanov, and A K Bogolepov
May 1974, Wiener medizinische Wochenschrift (1946),
G G Chichkanov, and A K Bogolepov
June 1971, Revista brasileira de medicina,
G G Chichkanov, and A K Bogolepov
May 1984, Biulleten' eksperimental'noi biologii i meditsiny,
G G Chichkanov, and A K Bogolepov
January 1981, Farmakologiia i toksikologiia,
G G Chichkanov, and A K Bogolepov
February 1981, Biulleten' eksperimental'noi biologii i meditsiny,
G G Chichkanov, and A K Bogolepov
January 1979, Farmakologiia i toksikologiia,
G G Chichkanov, and A K Bogolepov
January 1977, Roczniki Akademii Medycznej im. Juliana Marchlewskiego w Bialymstoku,
G G Chichkanov, and A K Bogolepov
January 1980, Farmakologiia i toksikologiia,
Copied contents to your clipboard!